Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
about
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.'Progressive MS - macro views': The need for novel clinical trial paradigms to enable drug development for progressive MS.Management of multiple sclerosis patients in central European countries: current needs and potential solutions.
P2860
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Highly active immunomodulatory ...... d advanced multiple sclerosis.
@en
Highly active immunomodulatory ...... d advanced multiple sclerosis.
@nl
type
label
Highly active immunomodulatory ...... d advanced multiple sclerosis.
@en
Highly active immunomodulatory ...... d advanced multiple sclerosis.
@nl
prefLabel
Highly active immunomodulatory ...... d advanced multiple sclerosis.
@en
Highly active immunomodulatory ...... d advanced multiple sclerosis.
@nl
P2093
P50
P356
P1476
Highly active immunomodulatory ...... d advanced multiple sclerosis.
@en
P2093
Alexandre Prat
Celia Oreja-Guevara
Cristina Ramo
Csilla Rozsa
Daniele Spitaleri
Edgardo Cristiano
Franco Granella
Francois Grand'Maison
Freek Verheul
P304
P356
10.1136/JNNP-2016-313976
P407
P50
P577
2016-09-28T00:00:00Z